# Pharma R&D Data Spine — Project Blueprint

**Status:** Architecture and implementation specification

## Business problem
Trace research evidence across ELN, LIMS, formulation, manufacturing and clinical systems from material and method to batch and study.

## Reference workflow
Source registration → experiment/sample ingestion → metadata harmonisation → lineage graph → governed dataset assembly → validation → research/clinical consumption.

## Logical architecture
Source adapters isolate ELN/LIMS/clinical or enterprise source formats; canonical models harmonise identity and metadata; transformation services create governed datasets; lineage services retain provenance; validation gates protect downstream use; access policy and audit govern consumption.

## Domain model
Study, Experiment, Sample, Material, Method, Result, Formulation, Batch, Protocol, Dataset, LineageEdge. Define stable IDs, source IDs, versioning, timestamps, provenance, ownership and lineage relationships.

## Code modules
source_connectors, metadata_model, sample_registry, identity_resolution, lineage_graph, dataset_builder, validation, access_policy, export. Separate ingestion, transformation, quality, catalog and orchestration concerns. Keep cloud/vendor-specific implementations behind replaceable adapters.

## Data architecture
Separate raw/immutable source evidence from standardised and curated datasets. Define schema contracts, data quality expectations, incremental processing, late-arriving data, lineage and retention. For regulated research, retain method, instrument/source, protocol and version context needed to reproduce results.

## Interfaces
Use versioned data contracts and APIs. Define batch and event ingestion separately. Include schema evolution, idempotency, checkpointing, replay and access controls.

## Security and governance
Use synthetic datasets, least privilege, encryption, metadata classification, lineage and auditable access. Define data retention and deletion constraints before implementation.

## NFRs
Measure data freshness, throughput, quality failure rate, reproducibility, recovery time and compute/storage cost. Test malformed schemas, duplicates, late events and failed pipeline stages.

## Delivery increments
1. Runnable project skeleton and canonical data contracts.
2. Local ingestion and transformation with fixtures.
3. Quality, lineage and incremental processing.
4. Orchestration, security, observability and CI.
5. Synthetic end-to-end pipeline and reproducible data-quality report.

## Acceptance criteria
Clean startup; contract validation; deterministic transformation tests; lineage and quality evidence; recoverable incremental runs; reproducible synthetic demo.
